Cage Pharma is a pre-clinical biopharmaceutical company that develops new drugs targeting the metabolism of tumors.
Business Model:
Revenue: $0
Employees: 1-10
Address:
City: Baltimore
State: Maryland
Zip:
Country: United States
Cage Pharma is a pre-clinical biopharmaceutical company that develops new drugs targeting the metabolism of tumors. The company&s;s encapsulated anti-cancer agent is developed using a novel formulation of a particular halopyruvate called 3-bromopyruvate to target cancer by directly attacking one of its key hallmarks, tumor glycolysis, enabling medical practitioners to achieve efficacy as an anti-cancer agent with a controlled and mild toxicity profile. Cage Pharma was founded in 2017 and is headquartered in Baltimore, Maryland.
Contact Phone:
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|
Announced Date | Transaction | Number of Investors | Money Raised | Lead Investors | 7/2019 | Seed Round | $480k |
---|
Announced Date | Name | Price |
---|
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|